Author:
Acharya N V,Wilton L V,Shakir S A W
Publisher
Springer Science and Business Media LLC
Subject
Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism,Medicine (miscellaneous)
Reference27 articles.
1. Drent ML, van der Veen EA . Lipase inhibition: a novel concept in the treatment of obesity. Int J Obes Relat Metab Disord 1993; 17: 241–244.
2. Royal College of Physicians Working Party. Overweight and Obese Patients: Principles of Management with Particular Reference to the Use of Drugs. The Royal College of Physicians: London, 1997.
3. Fricker J . Balancing the risks of anti-obesity pills. Lancet 1997; 349: 1374.
4. Roche Products Limited. Orlistat, Summary of Product Characteristics. August 1998.
5. Hollander P, Elbein SC, Hirsch IB, Kelley D, McGill J, Taylor T et al. Role of orlistat in the treatment of obese patients with type 2 diabetes: A 1-year randomized double-blind study. Diabet Care 1998; 21: 1288–1294.
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献